Global Diabetes Care Devices Market (2018-2025)-GMI Research Global Diabetes Care Devices Market (2018-2025)-GM | Page 2

Download Sample Brochure : https://www.gmiresearch.com/sample-research-
report.php?rid=129
Diabetes disease is a global concern and socioeconomic issue that affects
several million of person each year. Diabetes Care Devices is widely used in
diagnosis and treatment of diabetes, blood glucose monitoring devices and
insulin delivery devices have been broadly adopted worldwide to treat a
diabetes. For example, In 2015, according to IDF seventh Edition stated that
approximately 29.6 million of the adult population suffered from diabetes in in
the South and Central America regions of which about 39.0% of them were
undiagnosed.
Diabetes Care Devices market growth is mainly driven by factors such as
growing prevalence of diabetes, growing prevalence of obesity, rising diagnosis
rate in emerging countries, technological advancements in the field of diabetes
devices. In addition, rising disposable income in emerging countries and
government aids are also helping to increase treatment seeking rate which
further increases demand of Diabetes Care Devices which is expected to bolster
revenue growth of the market during the forecast period. However, inadequate
reimbursement scenario in emerging counties, lack of awareness about new
diabetes care devices may hinder the growth of this market during the forecast
period.
North-America is expected to dominate the market, followed by Europe
attributed to wing to the reimbursement facilities, and presence of large number
of companies which aid in product availability. Asia Pacific region is expected
to exhibit higher growth rate during the forecast period due to the presence of
large number of people with diabetes in this region and developing healthcare
facilities are expected to fuel the market growth. Improvement in the healthcare
infrastructure by increased government and private funding in emerging
economies is expected to boost the growth of the market.
Various notable players operating the Diabetes Care Devices market include
Abbott Laboratories, Bayer HealthCare AG, F. Hoffmann-La Roche Ltd, Terumo
Corporation, Glaxosmithkline Plc, Medtronic, Johnson & Johnson, Becton,
Dickinson and Company, Dexcom, Inc., Sanofi and others.
The global Diabetes Care Devices market has been segmented based on product
type, end user and key geographies. Based on Product type, the market
comprises of Blood Glucose Monitoring Devices and Insulin Delivery Devices.
This research report on Diabetes Care Devices market provides in-depth analysis
of the global Diabetes Care Devices market based on product type, end user and
major geographies for the forecast period from 2018 to 2025. The report